SE459712B - Farmaceutisk komposition foer perkutan administrering av ett fysiologiskt aktivt medel - Google Patents

Farmaceutisk komposition foer perkutan administrering av ett fysiologiskt aktivt medel

Info

Publication number
SE459712B
SE459712B SE8403487A SE8403487A SE459712B SE 459712 B SE459712 B SE 459712B SE 8403487 A SE8403487 A SE 8403487A SE 8403487 A SE8403487 A SE 8403487A SE 459712 B SE459712 B SE 459712B
Authority
SE
Sweden
Prior art keywords
carbon atoms
active agent
group containing
component
alkyl group
Prior art date
Application number
SE8403487A
Other languages
English (en)
Swedish (sv)
Other versions
SE8403487L (sv
SE8403487D0 (sv
Inventor
K Saito
J Heller
W A Skinner
Original Assignee
Nitto Electric Ind Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Electric Ind Co filed Critical Nitto Electric Ind Co
Publication of SE8403487D0 publication Critical patent/SE8403487D0/xx
Publication of SE8403487L publication Critical patent/SE8403487L/
Publication of SE459712B publication Critical patent/SE459712B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
SE8403487A 1983-07-01 1984-06-29 Farmaceutisk komposition foer perkutan administrering av ett fysiologiskt aktivt medel SE459712B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/510,133 US4590190A (en) 1983-07-01 1983-07-01 Method for percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent

Publications (3)

Publication Number Publication Date
SE8403487D0 SE8403487D0 (sv) 1984-06-29
SE8403487L SE8403487L (sv) 1985-01-02
SE459712B true SE459712B (sv) 1989-07-31

Family

ID=24029504

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8403487A SE459712B (sv) 1983-07-01 1984-06-29 Farmaceutisk komposition foer perkutan administrering av ett fysiologiskt aktivt medel

Country Status (10)

Country Link
US (1) US4590190A (de)
JP (1) JPS6013721A (de)
CA (1) CA1228027A (de)
CH (1) CH658994A5 (de)
DE (1) DE3424057C3 (de)
DK (1) DK315884A (de)
FR (1) FR2548025B1 (de)
GB (1) GB2142237B (de)
NL (1) NL8402046A (de)
SE (1) SE459712B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR940011209B1 (ko) * 1985-12-04 1994-11-29 시에 딘 약물의 경피 투여
US5023252A (en) * 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US4855132A (en) * 1986-02-25 1989-08-08 S R I International Method of preparing bioerodible polymers having pH sensitivity in the acid range and resulting product
US4764364A (en) * 1986-02-25 1988-08-16 S R I International Method of preparing bioerodible polymers having pH sensitivity in the acid range and resulting product
DE3617158C2 (de) * 1986-05-22 1994-10-06 Lohmann Therapie Syst Lts Transdermales Arzneimittel
US4808414A (en) * 1986-09-29 1989-02-28 Nelson Research & Development Co. Amide penetration enhancers for transdermal delivery of systemic agents
CH679119A5 (de) * 1988-05-13 1991-12-31 Sandoz Ag
JPH02104531A (ja) * 1988-10-14 1990-04-17 Toyo Jozo Co Ltd 経鼻投与用生理活性ペプチド組成物
US5026556A (en) * 1988-11-10 1991-06-25 Norwich Eaton Pharmaceuticals, Inc. Compositions for the transdermal delivery of pharmaceutical actives
US5183665A (en) * 1989-01-23 1993-02-02 Nitto Denko Corporation Composition for percutaneous administration and method for enhancing percutaneous absorption of a physiologically active ingredient empolying the same
JPH03236317A (ja) * 1989-12-06 1991-10-22 Sansei Seiyaku Kk ドパミン誘導体含有経皮用製剤
US5246949A (en) * 1989-12-06 1993-09-21 Sansho Co., Ltd. Preparation for endermism containing dopamine derivatives
JPH06510290A (ja) * 1991-08-27 1994-11-17 シグナス，インコーポレイテッド プラゾシンを投与するための経皮処方物
US5900250A (en) * 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
WO1994021262A1 (en) * 1993-03-17 1994-09-29 Alza Corporation Device for the transdermal administration of alprazolam
CA2167526A1 (en) * 1993-09-29 1995-04-06 Lina Tormen Taskovich Monoglyceride/lactate ester permeation enhancer
ES2188644T3 (es) * 1994-09-30 2003-07-01 Oreal Utilizacion de una sustancia agonista de un receptor asociado con un canal de cloro en el tratamiento de las arrugas.
US5693335A (en) * 1995-06-07 1997-12-02 Cygnus, Inc. Skin permeation enhancer composition for use with sex steroids
DE19725615A1 (de) * 1997-06-17 1998-12-24 Permamed Ag Zur topischen Applikation bestimmte Diclofenac-Lösung
US6491575B2 (en) * 1997-07-03 2002-12-10 Andreas Sarantitis Tool for the removal of paint-like materials from work surfaces
US7179483B2 (en) * 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
ES2294026T3 (es) * 2000-09-06 2008-04-01 Ap Pharma, Inc. Polimeros degradables de poliacetal.
US6590059B2 (en) * 2001-05-11 2003-07-08 Ap Pharma, Inc. Bioerodible polyorthoesters from dioxolane-based diketene acetals
US20030152630A1 (en) * 2001-05-11 2003-08-14 Ng Steven Y. PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
US6524606B1 (en) * 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups
US6828277B2 (en) * 2003-03-24 2004-12-07 E. I. Du Pont De Nemours And Company Production of N-aryl-2-lactam and N-alkyl-2-lactam by reductive amination of lactones with aryl and alkyl nitro compounds
US6900337B2 (en) * 2003-03-24 2005-05-31 E. I. Du Pont De Nemours And Company Production of 5-methyl-1-hydrocarbyl-2-pyrrolidone by reductive amination of levulinic acid
US20040192938A1 (en) * 2003-03-24 2004-09-30 Manzer Leo Ernest Production of 5-mehyl-N-aryl-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive of levulinic acid esters with aryl and alkyl amines
US6828278B2 (en) * 2003-03-24 2004-12-07 E.I. Du Pont De Nemours And Company Production of N-aryl-2-lactam and N-cycloalkyl-2-lactam by reductive amination of lactones with arly amines
US6818593B2 (en) * 2003-03-24 2004-11-16 E. I. Du Pont De Nemours And Company Production of 5-Methyl-N-aryl-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive amination of levulinic acid with nitro compounds
US6855731B2 (en) * 2003-03-24 2005-02-15 E. I. Du Pont De Nemours And Company Production of 5-methyl-N-aryl-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive amination of levulinic acid esters with nitro compounds
US20050158329A1 (en) * 2004-01-21 2005-07-21 Ghosh Swapan K. Novel phytol derived immunoadjuvants and their use in vaccine formulations
WO2007015441A1 (ja) * 2005-08-01 2007-02-08 Hisamitsu Pharmaceutical Co., Inc. 経皮または経粘膜投与のためのアジュバントおよび製剤
RU2011111206A (ru) * 2008-10-31 2012-12-10 Моберг Дерма Аб Композиции для местного применения, содержащие комбинацию по меньшей мере двух агентов, усиливающих проникновение
JP6114401B2 (ja) 2013-10-31 2017-04-12 久光製薬株式会社 アジュバント組成物、これを含むアジュバント製剤、及びキット

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1227617B (de) * 1961-07-20 1966-10-27 Dr Med Friedrich Meyer Penetrationsvermittler
FR2001768A1 (fr) * 1968-02-12 1969-10-03 Gillette Co Compositions pour l'application topique de medicaments sur la peau
US3551554A (en) * 1968-08-16 1970-12-29 Crown Zellerbach Corp Enhancing tissue penetration of physiologically active agents with dmso
GB1404583A (en) * 1971-10-08 1975-09-03 Vymatt Sa Urea compositions and methods of preparation thereof
SE7506731L (sv) * 1974-07-01 1976-01-02 Merck & Co Inc Komposition for behandling av akne.
DE2528516A1 (de) * 1974-07-05 1976-01-22 Sandoz Ag Neue galenische zubereitung
GB1504302A (en) * 1974-08-23 1978-03-15 Fisons Ltd Sedative method and composition
US3969516A (en) * 1974-12-19 1976-07-13 Nelson Research & Development Company Composition and method for treatment of acne
US4017641A (en) * 1975-01-31 1977-04-12 The Procter & Gamble Company Skin moisturizing compositions containing 2-pyrrolidinone
US3989816A (en) * 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
JPS52148614A (en) * 1976-06-04 1977-12-10 Masao Yonemushi Production of additive for skin medicine
US4202888A (en) * 1976-07-12 1980-05-13 Kali-Chemie Pharma Gmbh. Readily enterally absorbable pharmaceutical compositions of cardiac glycosides and preparation thereof
JPS557272A (en) * 1978-06-16 1980-01-19 Rech Pharma Sa Drug composition containing urea
CA1165240A (en) * 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone

Also Published As

Publication number Publication date
DE3424057A1 (de) 1985-01-10
DE3424057C2 (de) 1986-05-28
US4590190A (en) 1986-05-20
SE8403487L (sv) 1985-01-02
JPS6013721A (ja) 1985-01-24
JPS645579B2 (de) 1989-01-31
GB8415975D0 (en) 1984-07-25
GB2142237A (en) 1985-01-16
DE3424057C3 (de) 1992-05-07
FR2548025A1 (fr) 1985-01-04
CA1228027A (en) 1987-10-13
FR2548025B1 (fr) 1988-04-29
SE8403487D0 (sv) 1984-06-29
DK315884A (da) 1985-01-02
CH658994A5 (de) 1986-12-31
NL8402046A (nl) 1985-02-01
GB2142237B (en) 1987-09-23
DK315884D0 (da) 1984-06-28

Similar Documents

Publication Publication Date Title
SE459712B (sv) Farmaceutisk komposition foer perkutan administrering av ett fysiologiskt aktivt medel
US4752612A (en) Method and percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent
US4710497A (en) Method for percutaneously administering physiologically active agents
JPS60161918A (ja) メトクロプラミドの経皮投与法
ES2613721T3 (es) Composiciones y métodos para administración transdérmica de hormonas y otros agentes medicinales
CA2153166A1 (en) Enhanced pharmaceutical compositions for skin penetration
KR20030031568A (ko) 충분한 치료효과를 보장하는 활성 화합물의 경피 및/또는경점막 투여용 신규 조성물
ITMI961152A1 (it) Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
CA1225594A (en) Method for percutaneously administering physiologically active agents
US5128376A (en) Method for percutaneously administering physiologically active agents using an adjuvant a solvent and a diol moderator
JPS6185328A (ja) 経皮吸収促進剤及びこれを含有する皮膚外用剤
US5449670A (en) Composition and method for the transdermal delivery of bioactive peptides
CA1227753A (en) Method for percutaneously administering physiologically active agents using an adjuvant, a solvent and a diol moderator
JPS6133129A (ja) 基剤組成物および外用医薬組成物
JPS60228423A (ja) 基剤組成物および外用医薬組成物
US5183665A (en) Composition for percutaneous administration and method for enhancing percutaneous absorption of a physiologically active ingredient empolying the same
JP2906146B2 (ja) 経皮投与組成物
JPH02258730A (ja) 外用医薬組成物
JPH06184000A (ja) （−）−イソプレゴールからなる経皮吸収促進剤
JP2782118B2 (ja) 経皮吸収促進組成物及び経皮外用組成物
JPH0948739A (ja) 抗炎症医薬組成物
EP0428272A2 (de) Trifluorobenzodiazepin-Verbindungen zur Verwendung in Therapie mittels intraoraler Verabreichung
JPS6287528A (ja) Ｎ−アルキルモルホリン含有外皮投与用組成物
JPS61129139A (ja) 外皮投与用組成物
JPS60243015A (ja) 塩酸ニカルジピンの外用剤

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8403487-5

Effective date: 19940110

Format of ref document f/p: F